The present invention relates to a pharmaceutical composition for treating and preventing degenerative neurological disorders, containing, as an active ingredient, a mixture extract of two or more types selected from the group consisting of Moutan Root Bark, Angelica Dahurica Root, and Bupleurum Root, or a fraction thereof. Specifically, the extract of the mixture of the present invention exhibits a recovery effect on mitochondrial function damage, a relieving effect on endoplasmic reticulum stress and also exhibits simultaneously an inhibitory effect on inflammatory response, which are remarkably improved compared with those exhibited in an in vitro single extract, and the extract of the mixture significantly exhibits an improvement effect on motor coordination and a protective effect on dopaminergic neurons in a Parkinson's disease animal model, and thus the extract of the mixture of the present invention or a fraction thereof can be useful as an active ingredient of a pharmaceutical composition for treating and preventing degenerative neurological disorders.

A fasting mimicking diet package providing breakfast, lunch, and dinner meal portions for consumption during a one-day or single day fast. The one-day fasting mimicking diet package includes breakfast, lunch, and dinner meal portions for the one-day fast. The FMD package includes a breakfast meal portion having a first nut-containing nutrition bar composition, a micronutritional vegetable powder composition including vitamin and mineral supplements, an algal oil composition, a lunch meal portion that incorporates a first soup composition and a kale cracker composition, and a dinner meal portion having a second soup composition, one of either the kale cracker composition or an olive containing composition, and a second nut containing nutrition bar composition.

The invention relates to a high melting point chicken fat produced by dry fractionation of semi-liquid chicken fat. In particularly the invention relates to a chicken fat wherein the chicken fat having a total saturated fat content of 48 to 72 wt % (based on weight of total fat) comprising the fatty acids C16:0 in the range of 36 to 55 wt % (based on weight of total fat) and C18:0 in the range of 11 to 19 wt % (based on weight of total fat).

The invention relates to a high melting point chicken fat produced by dry fractionation of semi-liquid chicken fat. In particularly the invention relates to a chicken fat wherein the chicken fat having a total saturated fat content of 48 to 72 wt % (based on weight of total fat) comprising the fatty acids C16:0 in the range of 36 to 55 wt % (based on weight of total fat) and C18:0 in the range of 11 to 19 wt % (based on weight of total fat).

The present invention relates to a flavour mixture containing 2E,4Z,7Z- and 2E,4E,7Z-tridecatrienal. This flavour mixture can be produced advantageously from arachidonic acid or oils containing esters thereof.

The present invention relates to a flavour mixture containing 2E,4Z,7Z- and 2E,4E,7Z-tridecatrienal. This flavour mixture can be produced advantageously from arachidonic acid or oils containing esters thereof.

The present invention relates to a savoury, particulate composition having a water content of not more than 15 wt. % and comprising:

a) 5-99 wt. %, by weight of the composition, tomato powder, wherein at least 70 wt. % of said tomato powder has a mesh size of less than 850 μm,
b) 0.5-5 wt. %, by weight of the tomato powder, calcium carbonate powder, said calcium carbonate powder having a volume median grain diameter (D50) of 0.1-50 μm.

The present invention relates to a savoury, particulate composition having a water content of not more than 15 wt. % and comprising:

a) 5-99 wt. %, by weight of the composition, tomato powder, wherein at least 70 wt. % of said tomato powder has a mesh size of less than 850 μm,
b) 0.5-5 wt. %, by weight of the tomato powder, calcium carbonate powder, said calcium carbonate powder having a volume median grain diameter (D50) of 0.1-50 μm.

The invention relates to a bouillon tablet comprising 20-70 wt % crystalline salt, up to 15 wt % crystalline sugar and 10-70 wt % pieces of plant material, wherein the crystalline salt has a median particle diameter Dv50 in the range of 0.7 to 3.5 mm, wherein the crystalline sugar has a median particle diameter Dv50 in the range of 0.5 to 3.5 mm and the pieces of plant material have a median particle diameter Dv50 in the range of 0.7 to 9.0 mm.

The invention relates to a bouillon tablet comprising 20-70 wt % crystalline salt, up to 15 wt % crystalline sugar and 10-70 wt % pieces of plant material, wherein the crystalline salt has a median particle diameter Dv50 in the range of 0.7 to 3.5 mm, wherein the crystalline sugar has a median particle diameter Dv50 in the range of 0.5 to 3.5 mm and the pieces of plant material have a median particle diameter Dv50 in the range of 0.7 to 9.0 mm.